PharmaVentures acts as advisor and broker to Dr Reddy’s to identify and secure product marketing opportunities for the Russian/CIS market.

Oxford, UK, 26th October, 2010: PharmaVentures Ltd announced today that it had acted as the advisor and broker to the Indian pharmaceutical company Dr Reddy’s Laboratories in its successful marketing and distribution agreement with the UK healthcare company Vitabiotics Ltd for a range of nutraceutical products. The agreement provides Dr Reddy’s exclusive marketing rights in the Russian/CIS markets for two of Vitabiotics’ leading products - Jointace and Dietrim. Vitabiotics will supply these products on a long-term basis from its facilities in Europe.

PharmaVentures acts as exclusive advisor to sanofi-aventis in landmark divestment deal with Covance

Oxford, UK. 01 October 2010 - PharmaVentures are pleased to announce that they acted as transaction advisors and sale process executioners for sanofi-aventis in their strategic deal with Covance. Under the terms of the agreement, sanofi-aventis will retain access to some of the capabilities which have been divested to Covance as part of a long-term strategic alliance. Covance will provide sanofi-aventis with a 10-year sole source relationship for central lab services.


Watch our new promotional video



PharmaVentures InSights